Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07883759 |
| Title | Neoadjuvant Pembrolizumab in Patients With High Risk, Stage IIB/IIC Cutaneous Melanoma: a Single Arm Proof of Concept Phase IIA Study. (NEOSTART) |
| Acronym | NEOSTART |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Centre Hospitalier Universitaire de Besancon |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA |